Clara Biotech is Discovery Tools (Healthcare) in United States that focus on biopharma companies business. Founded in 2018. They cover business area such as developer, exosome isolation and purification platform, exosome harvesting, future breakthrough medicine, purity, potency, safety, addition, therapeutic, unique liquid biopsy, cancer, non-exosome content, mirna signal, challenge.
2018
( 6 years old in 2024 )
Biopharma Companies
-
2029 Becker Drive
Suite 233
Lawrence, KS 66047
United States
Private
developerexosome isolation and purification platformexosome harvestingfuture breakthrough medicinepuritypotencysafetyadditiontherapeuticunique liquid biopsycancernon-exosome contentmirna signalchallenge
* We use standard office opening hours in near Clara Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Clara Biotech is Discovery Tools (Healthcare) business from United States that founded in 2018 (6 years old in 2024), Clara Biotech business is focusing on Biopharma Companies.
Clara Biotech headquarter office and corporate office address is located in 2029 Becker Drive Suite 233 Lawrence, KS 66047 United States.
Clara Biotech was founded in United States.
In 2024, Clara Biotech is currently focus on biopharma companies sector.
Above is snippet of Google Trends for "biopharma companies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Clara Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
